Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production

• Zhenhua Ma ,

  Contributed equally to this work with: Zhenhua Ma, Yangmin Zhang, Qingchun Li

  Roles Writing – original draft

  Affiliation Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China

  ⨯
• Yangmin Zhang ,

  Contributed equally to this work with: Zhenhua Ma, Yangmin Zhang, Qingchun Li

  Roles Data curation

  Affiliation Department of Blood Transfusion, Xi’an Central Hospital, Xi'an, Shaanxi, P.R. China

  ⨯
• Qingchun Li ,

  Contributed equally to this work with: Zhenhua Ma, Yangmin Zhang, Qingchun Li

  Roles Data curation

  Affiliation The Third Hepatic Disease Ward, The Affiliated Xi'an Eighth Hospital, Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China

  ⨯
• Meng Xu,

  Roles Methodology

  Affiliation Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China

  ⨯
• Jigang Bai,

  Roles Validation

  Affiliation Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China

  ⨯
• Shengli Wu

  Roles Writing – review & editing

  * E-mail: victorywu2000@163.com

  Affiliation Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China

  http://orcid.org/0000-0001-9882-3504

  ⨯